Nordhealth AS

OB:NORDH Stock Report

Market Cap: NOK 3.1b

Nordhealth Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Charles MacBain

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership44.2%
Management average tenureno data
Board average tenure3.9yrs

Recent management updates

Recent updates

We're Not Very Worried About Nordhealth's (OB:NORDH) Cash Burn Rate

Sep 28
We're Not Very Worried About Nordhealth's (OB:NORDH) Cash Burn Rate

Here's Why We're Not Too Worried About Nordhealth's (OB:NORDH) Cash Burn Situation

May 10
Here's Why We're Not Too Worried About Nordhealth's (OB:NORDH) Cash Burn Situation

Nordhealth AS' (OB:NORDH) 25% Jump Shows Its Popularity With Investors

Apr 10
Nordhealth AS' (OB:NORDH) 25% Jump Shows Its Popularity With Investors

What You Can Learn From Nordhealth AS' (OB:NORDH) P/S

Feb 23
What You Can Learn From Nordhealth AS' (OB:NORDH) P/S

Nordhealth (OB:NORDH) Is In A Good Position To Deliver On Growth Plans

Jan 03
Nordhealth (OB:NORDH) Is In A Good Position To Deliver On Growth Plans

Getting In Cheap On Nordhealth AS (OB:NORDH) Might Be Difficult

May 12
Getting In Cheap On Nordhealth AS (OB:NORDH) Might Be Difficult

Estimating The Intrinsic Value Of Nordhealth AS (OB:NORDH)

Jan 25
Estimating The Intrinsic Value Of Nordhealth AS (OB:NORDH)

CEO

Charles MacBain

no data

Tenure

Mr. Charles MacBain serves as Chief Executive Officer of Nordhealth AS.

Board Members

NamePositionTenureCompensationOwnership
Janne Huttunen
Chief Innovation Officer of Veterinary & Board Member3.9yrsno data4.02%
NOK 126.4m
Philippe Vimard
Director1.7yrsno data0.11%
NOK 3.5m
Didier Breton
Chairman of the board3.9yrsno data0.25%
NOK 8.0m

3.9yrs

Average Tenure

Experienced Board: NORDH's board of directors are considered experienced (3.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 23:01
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nordhealth AS is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristian StøleCarnegie Investment Bank AB